No treatment, just data: new study tracks rare metabolic disease
NCT ID NCT05769621
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is not testing any new drug or treatment. Instead, researchers will look back at medical records of 60 people with propionic acidemia, a rare genetic disorder that affects how the body breaks down certain proteins and fats. The goal is to better understand the disease, including how often patients have serious metabolic episodes and need hospital care. This information could help design future studies and improve care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROPIONIC ACIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ASST di Monza - Azienda Ospedaliera San Gerardo
ACTIVE_NOT_RECRUITINGMonza, Monza A Brianza, 20900, Italy
-
Azienda Ospedaliera Universitaria Federico II
RECRUITINGNaples, Campania, 80131, Italy
-
Azienda Ospedaliero Universitaria A Meyer - INCIPIT - PIN
RECRUITINGFlorence, Tuscany, 50139, Italy
-
CHRU Nancy Hôpital des Enfants
WITHDRAWNVandœuvre-lès-Nancy, Meurthe-et-Moselle, 54511, France
-
CHU Toulouse
RECRUITINGToulouse, Haute-Garonne, 31300, France
-
CHU de Marseille - Hôpital de la Timone
RECRUITINGMarseille, 13386, France
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Erasmus MC
NOT_YET_RECRUITINGRotterdam, South Holland, 3015 GD, Netherlands
-
Fujita Health University Hospital
NOT_YET_RECRUITINGToyoake, Aichi-ken, 470-1192, Japan
-
Great Ormond Street Hospital
ACTIVE_NOT_RECRUITINGCity of London, London, United Kingdom
-
Hospital Sant Joan de Deu
RECRUITINGEsplugues de Llobregat, Barcelona, 8950, Spain
-
Hospital Universitari I Politecnic La Fe de Valencia
RECRUITINGValencia, 46026, Spain
-
Hospital Universitario 12 de Octubre
ACTIVE_NOT_RECRUITINGMadrid, 28041, Spain
-
Hospital Universitario Cruces
RECRUITINGBarakaldo, 48903, Spain
-
Hospital Universitario Marques de Valdecilla
RECRUITINGSantander, Cantabria, 39008, Spain
-
Hospital Universitario Raymon y Cajal
RECRUITINGMadrid, 28034, Spain
-
Hospital Universitario Virgen del Rocio - PPDS
RECRUITINGSeville, 41013, Spain
-
Hôpital Necker - Enfants Malades
RECRUITINGParis, Paris, 75743, France
-
Johns Hopkins University
RECRUITINGBaltimore, Maryland, 21287-0010, United States
-
Royal Children's Hospital Melbourne
WITHDRAWNParkville, Victoria, 3052, Australia
-
Seattle Children's Hospital
RECRUITINGSeattle, Washington, 98105-3901, United States
-
St Mary's Hospital - PPDS
ACTIVE_NOT_RECRUITINGManchester, Lancashire, United Kingdom
-
Stollery Children's Hospital University of Alberta
WITHDRAWNEdmonton, Alberta, T6G 2B7, Canada
-
Texas Children's Hospital
TERMINATEDHouston, Texas, 77030-2614, United States
-
The Jikei University School of Medicine
NOT_YET_RECRUITINGMinato, Tokyo, 105-8471, Japan
-
University Hospital Birmingham
RECRUITINGBirmingham, B29 6JD, United Kingdom
-
University of Michigan Hospital
ACTIVE_NOT_RECRUITINGAnn Arbor, Michigan, 48109-5000, United States
-
University of Stanford Medical Center
NOT_YET_RECRUITINGStanford, California, 94305-2200, United States
-
Victoria Hospital
WITHDRAWNKirkcaldy, Fife, KY2 5AH, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Newborn screening study aims to catch rare diseases at birth
- Experimental gene therapy targets rare metabolic disease in toddlers
- Medical records reveal clues to rare genetic disease in amish and mennonite populations
- New mRNA treatment for rare metabolic disease moves to Long-Term safety check
- Scientists launch Largest-Ever study to unravel rare metabolic disease
- MRNA therapy takes on rare metabolic disease